Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-019988

Chief Financial Officer sold 5,582 shares at an average $5.32 ($29,675)

From the SEC's structured data for this filing

Trades in this filing

Koppikar Utpal · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-17 Sale : show line 1 in the form −4,616 $5.32 $24,539 208,558 D
2022-05-17 Sale : show line 2 in the form −966 $5.32 $5,136 207,592 D
Open-market sales · 5,582 sh · avg $5.32 · $29,675
Loading xslF345X03/form4.xml…